Cargando…
A Novel CpG Methylation Risk Indicator for Predicting Prognosis in Bladder Cancer
PURPOSE: Bladder cancer (BLCA) is one of the most common cancers worldwide. In a large proportion of BLCA patients, disease recurs and/or progress after resection, which remains a major clinical issue in BLCA management. Therefore, it is vital to identify prognostic biomarkers for treatment stratifi...
Autores principales: | Guo, Yufeng, Yin, Jianjian, Dai, Yuanheng, Guan, Yudong, Chen, Pinjin, Chen, Yongqiang, Huang, Chenzheng, Lu, Yong-Jie, Zhang, Lirong, Song, Dongkui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440888/ https://www.ncbi.nlm.nih.gov/pubmed/34540821 http://dx.doi.org/10.3389/fcell.2021.642650 |
Ejemplares similares
-
Editorial: Beyond CpG Methylation: New Modifications in Eukaryotic DNA
por: Stöger, Reinhard, et al.
Publicado: (2018) -
Developmental Accumulation of Gene Body and Transposon Non-CpG Methylation in the Zebrafish Brain
por: Ross, Samuel E., et al.
Publicado: (2021) -
Discovered Key CpG Sites by Analyzing DNA Methylation and Gene Expression in Breast Cancer Samples
por: Cao, Yan-Ni, et al.
Publicado: (2022) -
Intragenic CpG Islands and Their Impact on Gene Regulation
por: Cain, James A., et al.
Publicado: (2022) -
Preservation of methylated CpG dinucleotides in human CpG islands
por: Panchin, Alexander Y., et al.
Publicado: (2016)